ANXA5 and hepatocellular carcinoma: High levels of ANXA5 correlated with the up-regulation of the two isoforms of the adapter molecule crk (CRKI/II) and the Ras-related C3 botulinum toxin substrate 1 (RAC1) in HCC tissues, potentially increasing the clinical progression and the lymphatic metastasis of patients.